uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Tidhesco
Application withdrawn
Human
Orphan medicine
Details
EMA number
EMEA/H/C/006174
ATC code
L01XX62
Authorisation
-
Revision
-
EMA page
Therapeutic indication
Treatment of newly diagnosed acute myeloid leukaemia
MeSH:
Leukemia, Myeloid, Acute
Group:
Antineoplastic agents
Active substances
Ivosidenib
Marketing Authorisation Holder
Les Laboratoires Servier
MAH
Tidhesco | uMedical